Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Amortization - Intangibles: 2016-2018

Historic Amortization - Intangibles for Ironwood Pharmaceuticals (IRWD) over the last 2 years, with Sep 2018 value amounting to $1.2 million.

  • Ironwood Pharmaceuticals' Amortization - Intangibles fell 38.90% to $1.2 million in Q3 2018 from the same period last year, while for Sep 2018 it was $11.6 million, marking a year-over-year increase of 91.90%. This contributed to the annual value of $8.1 million for FY2018, which is 30.53% up from last year.
  • Per Ironwood Pharmaceuticals' latest filing, its Amortization - Intangibles stood at $1.2 million for Q3 2018, which was down 66.66% from $3.5 million recorded in Q2 2018.
  • Ironwood Pharmaceuticals' Amortization - Intangibles' 5-year high stood at $3.5 million during Q4 2017, with a 5-year trough of $420,000 in Q1 2017.
  • Its 3-year average for Amortization - Intangibles is $2.3 million, with a median of $3.2 million in 2016.
  • Per our database at Business Quant, Ironwood Pharmaceuticals' Amortization - Intangibles plummeted by 40.72% in 2017 and then surged by 727.62% in 2018.
  • Ironwood Pharmaceuticals' Amortization - Intangibles (Quarterly) stood at $3.3 million in 2016, then rose by 5.33% to $3.5 million in 2017, then slumped by 38.90% to $1.2 million in 2018.
  • Its last three reported values are $1.2 million in Q3 2018, $3.5 million for Q2 2018, and $3.5 million during Q1 2018.